Literature DB >> 17600224

Murine models of vascular thrombosis (Eitzman series).

Randal J Westrick1, Mary E Winn, Daniel T Eitzman.   

Abstract

Thrombotic complications of vascular disease are the leading cause of morbidity and mortality in most industrialized countries. Despite this, safe and effective drugs targeting these complications are limited, especially in the chronic setting. This is because of the complexity of thrombosis in both arteries and veins, which is becoming increasingly evident as numerous factors are now known to affect the fate of a forming thrombus. To fully characterize thrombus formation in these settings, in vivo models are necessary to study the various components and intricate interactions that are involved. Genetic manipulations in mice are greatly facilitating the dissection of relevant pro- and antithrombotic influences. Standardized models for the study of thrombosis in mice as well as evolving techniques that allow imaging of molecular events during thrombus formation are now available. This review will highlight some of the recent developments in the field of thrombosis using mouse models and how these studies are expanding our knowledge of thrombotic disease.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17600224     DOI: 10.1161/ATVBAHA.107.142810

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  73 in total

1.  Injury measurements improve interpretation of thrombus formation data in the cremaster arteriole laser-induced injury model of thrombosis.

Authors:  Steven P Grover; Pavan K Bendapudi; Moua Yang; Glenn Merrill-Skoloff; Vijay Govindarajan; Alexander Y Mitrophanov; Robert Flaumenhaft
Journal:  J Thromb Haemost       Date:  2020-10-29       Impact factor: 5.824

2.  Resolving the multifaceted mechanisms of the ferric chloride thrombosis model using an interdisciplinary microfluidic approach.

Authors:  Jordan C Ciciliano; Yumiko Sakurai; David R Myers; Meredith E Fay; Beatrice Hechler; Shannon Meeks; Renhao Li; J Brandon Dixon; L Andrew Lyon; Christian Gachet; Wilbur A Lam
Journal:  Blood       Date:  2015-04-30       Impact factor: 22.113

3.  A microfluidic model of hemostasis sensitive to platelet function and coagulation.

Authors:  R M Schoeman; K Rana; N Danes; M Lehmann; J A Di Paola; A L Fogelson; K Leiderman; K B Neeves
Journal:  Cell Mol Bioeng       Date:  2016-10-24       Impact factor: 2.321

4.  What is vinculin needed for in platelets?

Authors:  J V Mitsios; N Prevost; A Kasirer-Friede; E Gutierrez; A Groisman; C S Abrams; Y Wang; R I Litvinov; A Zemljic-Harpf; R S Ross; S J Shattil
Journal:  J Thromb Haemost       Date:  2010-10       Impact factor: 5.824

5.  PET imaging of chemokine receptors in vascular injury-accelerated atherosclerosis.

Authors:  Yongjian Liu; Richard Pierce; Hannah P Luehmann; Terry L Sharp; Michael J Welch
Journal:  J Nucl Med       Date:  2013-05-08       Impact factor: 10.057

6.  Endogenous and natural complement inhibitor attenuates myocardial injury and arterial thrombogenesis.

Authors:  Vasile I Pavlov; Mikkel-Ole Skjoedt; Ying Siow Tan; Anne Rosbjerg; Peter Garred; Gregory L Stahl
Journal:  Circulation       Date:  2012-10-02       Impact factor: 29.690

Review 7.  Animal models of venous thrombosis.

Authors:  Hassan Albadawi; Avery A Witting; Yash Pershad; Alex Wallace; Andrew R Fleck; Peter Hoang; Ali Khademhosseini; Rahmi Oklu
Journal:  Cardiovasc Diagn Ther       Date:  2017-12

8.  Human mannose-binding lectin inhibitor prevents myocardial injury and arterial thrombogenesis in a novel animal model.

Authors:  Vasile I Pavlov; Ying S Tan; Erin E McClure; Laura R La Bonte; Chenhui Zou; William B Gorsuch; Gregory L Stahl
Journal:  Am J Pathol       Date:  2014-12-04       Impact factor: 4.307

9.  Differential effects of medroxyprogesterone acetate on thrombosis and atherosclerosis in mice.

Authors:  Till Freudenberger; Marc Oppermann; Andrea Marzoll; Hans-Karl Heim; Peter Mayer; Georg Kojda; Artur A Weber; Karsten Schrör; Jens W Fischer
Journal:  Br J Pharmacol       Date:  2009-12       Impact factor: 8.739

10.  Ir-CPI, a coagulation contact phase inhibitor from the tick Ixodes ricinus, inhibits thrombus formation without impairing hemostasis.

Authors:  Yves Decrem; Géraldine Rath; Virginie Blasioli; Philippe Cauchie; Séverine Robert; Jérôme Beaufays; Jean-Marie Frère; Olivier Feron; Jean-Michel Dogné; Chantal Dessy; Luc Vanhamme; Edmond Godfroid
Journal:  J Exp Med       Date:  2009-10-05       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.